imatinib mesylate has been researched along with Neurilemoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okano, M; Sakata, N; Takemura, T; Ueda, S | 1 |
| Beckman, MJ; de Stanchina, E; Dematteo, RP; Patwardhan, PP; Schwartz, GK; Surriga, O; Tap, WD | 1 |
| Awny, S; Elalfy, AF; Megahed, N; Metwally, IH | 1 |
| Bachmann, K; Bogoevski, D; Izbicki, J; Kaifi, J; Kohrs, D; Reichelt, U; Schurr, P; Vashist, Y; Yekebas, E | 1 |
| Balasubramaniam, A; Guha, A; Kamnasaran, D; Kiehl, TR; Mukherjee, J; Radovanovic, I; Zadeh, G | 1 |
| Ammoun, S; Hanemann, CO; Manley, P; Schmid, MC; Triner, J | 1 |
| Büchner-Steudel, P; Fleig, WE | 1 |
| Gebauer, B; Hohenberger, P; Reichardt, P; Wardelmann, E | 1 |
2 review(s) available for imatinib mesylate and Neurilemoma
| Article | Year |
|---|---|
[Diagnosis and conservative treatment of gastrointestinal stromal tumors (GIST)].
Topics: Antineoplastic Agents; Benzamides; Diagnosis, Differential; Endoscopy, Gastrointestinal; Endosonography; Enzyme Inhibitors; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Leiomyoma, Epithelioid; Leiomyosarcoma; Male; Mesenchymoma; Neurilemmoma; Piperazines; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Sex Factors; Tomography, X-Ray Computed | 2004 |
[Gastrointestinal stromal tumors (GIST)--current concepts of surgical management].
Topics: Benzamides; Chemotherapy, Adjuvant; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Leiomyoma; Leiomyoma, Epithelioid; Leiomyosarcoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neurilemmoma; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Risk Factors | 2004 |
6 other study(ies) available for imatinib mesylate and Neurilemoma
| Article | Year |
|---|---|
Appropriate modulation of autophagy sensitizes malignant peripheral nerve sheath tumor cells to treatment with imatinib mesylate.
Topics: Adenine; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Benzamides; Blotting, Western; Cell Survival; Flow Cytometry; Humans; Imatinib Mesylate; Membrane Proteins; Neurilemmoma; Phagosomes; Piperazines; Pyrimidines; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured | 2014 |
Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Humans; Imatinib Mesylate; Macrophages; Mice; Mice, Inbred ICR; Mice, SCID; Neurilemmoma; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Sirolimus; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Meckel's diverticulum complicated with gastro-intestinal stromal tumor: Case report.
Topics: Antineoplastic Agents; Biopsy; Chemotherapy, Adjuvant; Diagnosis, Differential; Digestive System Surgical Procedures; Egypt; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Male; Meckel Diverticulum; Middle Aged; Neurilemmoma; Pelvic Pain; Tomography, X-Ray Computed; Ultrasonography | 2016 |
Repeated surgery improves survival in recurrent gastrointestinal stromal tumors: a retrospective analysis of 144 patients.
Topics: Antineoplastic Agents; Benzamides; Clinical Protocols; Combined Modality Therapy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Leiomyoma; Leiomyosarcoma; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Piperazines; Pyrimidines; Reoperation; Retrospective Studies; Treatment Outcome | 2009 |
Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate).
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Neurilemmoma; Piperazines; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor | 2009 |
Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Humans; Imatinib Mesylate; Immunoblotting; MAP Kinase Signaling System; Neurilemmoma; Neurofibromatosis 2; Neurofibromin 2; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Signal Transduction | 2011 |